Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4797134 | 0.87 | GCK (0.78) | GCKKCNH2 | |
| SCHEMBL2659590 | 0.87 | GCK (0.78) | GCKKCNH2 | |
| SCHEMBL1147137 | 0.80 | GCK (0.85) | GCKKCNH2 | |
| SCHEMBL13891546 | 0.80 | GCK (0.85) | GCKKCNH2 | |
| SCHEMBL2655642 | 0.80 | GCK (1.00) | GCKKCNH2 | |
| SCHEMBL1427149 | 0.80 | GCK (0.64) | GCKKCNH2 | |
| SCHEMBL1147139 | 0.79 | GCK (0.78) | GCKKCNH2 | |
| SCHEMBL2905305 | 0.78 | GCK (0.63) | GCKKCNH2 | |
| SCHEMBL4794169 | 0.78 | GCK (0.63) | GCKKCNH2 | |
| SCHEMBL12510634 | 0.76 | GCK (0.61) | GCKKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1992623-A1 | Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes | Astra Zeneca AB (SE) | 2008-11-19 | — | — | EP | disclosed |